Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 7 (NDUFA5P7) is classified as a pseudogene derived from the NDUFA5 gene, which normally encodes a component of mitochondrial Complex I. Unlike its parent gene, NDUFA5P7 does not produce a functional protein and is not involved in enzymatic activity, electron transport, or any known biological process. Pseudogenes are generally considered non-functional remnants of evolutionary gene duplication or mutation and are not targets for drug development[1]. NDUFA5P7 is not a functional target or receptor—it is a non-protein-coding pseudogene, and there is no evidence for therapeutic, biomarker, drug, or protein function relevance[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 7 (NDUFA5P7).